Related Articles
MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non‑small cell lung cancer
Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)
Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review)
Significance of PD‑L1 clones and C‑MET expression in hepatocellular carcinoma
Tumor microenvironment classification based on T‑cell infiltration and PD‑L1 in patients with mismatch repair‑proficient and ‑deficient colorectal cancer